Check-Cap(CHEK)
Search documents
Check-Cap(CHEK) - 2023 Q4 - Annual Report
2024-05-15 20:01
● We are substantially dependent on our remaining key employees to facilitate the consummation of a strategic transaction; and ● If the Business Combination is not completed, and we do not pursue an alternative strategic option or liquidation, we expect that we will require significant additional funding in order to complete the development, scale up manufacturing and commercialization of C-Scan or any new products and technology. If additional capital is not available, we may have to cease operations. Risk ...
Check-Cap(CHEK) - 2023 Q3 - Quarterly Report
2023-11-26 16:00
Exhibit 99.1 Check-Cap shareholders to vote on proposed Business Combination Agreement with Keystone Dental at Annual General Meeting on Monday, December 18th ISFIYA, Israel, Nov. 27, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), today announced financial results and provided a corporate update for the third quarter and nine months ended September 30, 2023. • In August 2023, Keystone Dental and Check-Cap announced entering into a definitive Business Combination Agreement ...
Check-Cap(CHEK) - 2023 Q2 - Quarterly Report
2023-05-10 16:00
Exhibit 99.2 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 Table of Contents Page Financial Statements: Consolidated Unaudited Balance Sheets 3 Consolidated Unaudited Statements of Comprehensive Loss 4 Consolidated Unaudited Statements of Changes in Shareholders Equity 5 Consolidated Unaudited Statements of Cash Flows 6-7 Notes to Consolidated Unaudited Financial Statements 8-12 CHECK CAP LTD CONS ...
Check-Cap(CHEK) - 2022 Q4 - Annual Report
2023-03-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the ...
Check-Cap(CHEK) - 2023 Q1 - Quarterly Report
2023-03-30 16:00
Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results ISFIYA, Israel, March 31, 2023 -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparationfree screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced financial results for the fourth quarter and full year ended December 31, 2022. • In Marc ...
Check-Cap(CHEK) - 2022 Q3 - Quarterly Report
2022-11-29 16:00
Exhibit 99.1 Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update ISFIYA, Israel, November 30, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced financial results and provided a corporate update for th ...
Check-Cap(CHEK) - 2022 Q2 - Quarterly Report
2022-05-31 16:00
Exhibit 99.1 Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update Company initiated first part of its U.S. pivotal study in early May 2022 ISFIYA, Israel, June 1, 2022 -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparationfree screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced ...
Check-Cap(CHEK) - 2021 Q4 - Annual Report
2022-04-06 20:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the ...
Check-Cap(CHEK) - 2022 Q1 - Quarterly Report
2022-04-06 16:00
Exhibit 99.1 Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel, April 7, 2022 -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparationfree screening test to detect polyps before they may transform into colorectal cancer (CRC), toda ...
Check-Cap(CHEK) - 2020 Q4 - Annual Report
2021-03-18 20:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the ...